Clinical trial for the evaluation of the efficacy and safety of NAO on serum cholesterol

Efficacy and safety of NAO on serum cholesterol; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003878

Enrollment

100

Registered

2019-05-02

Start date

2019-04-17

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The participants enrolled in this study was assigned to 2 groups by double-blinde randomization. NAO group: Take NAO with water, 1bag/1time, 2time/1day, 12weeks placebo group: T

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Male and female subject aged between 20 years and 75 years 2) Subjects with Serum total cholesterol 200~249mg/dl or LDL-cholesterol 130~170mg/dl

Exclusion criteria

Exclusion criteria: 1) cholesterol medications within the past 3 months 2) Subjects who drinks alcohol more than 4 times per a week 3) Subjects with Gallbladder disease or gout, porphyrias 4) Subjects with CNS disorder (depressive disorder, schizophrenia, alcoholism, drug addiction) 5) Subjects with malnutrition

Design outcomes

Primary

Measure	Time frame
Total cholesterol;LDL-cholesterol;HDL-cholesterol;Triglyceride;Apolipoprotein A1;Apolipoprotein B;Lipoprotein (a);Atherogenic index;BMI(Body Mass Index)	—

Secondary

Measure	Time frame
Adverse event;clinical lab;vital sign;body weight;electrocardiogram	—

Countries

Korea, Republic of

Contacts

Public ContactYONGKYUN ROH

Hallym University Medical Center-Kangnam

rohyk@hallym.or.kr+82-2-829-5270

Outcome results